Hao Bai International (Cayman) Limited Overview
Hao Bai International is a Hong Kong-based micro-cap contractor listed on GEM. Its heritage is the design, procurement, installation and maintenance of water circulation systems: swimming pools, fountains and water curtains for developers, main contractors and subcontractors on residential, hotel, casino, retail and leisure projects. After listing in 2017, the core contracting franchise shrank. From 2022 the group pursued diversification through mainland consultancy and EPCM services, a Hong Kong construction acquisition, agricultural branding tie-ups and, from early 2026, PRC trading in food and health products. FY2026 revenue was HK$19.3m with a negative gross margin. The group made a HK$30.3m loss, driven by HK$32.8m of impairments on contract assets and receivables. It has been recapitalised repeatedly: placings, an open offer, four debt-for-equity swaps, a capital reorganisation and a 4-for-1 rights issue. Management is now targeting government-related renovation tenders in Hong Kong. The equity trades at roughly 20× book and 15× sales, a valuation detached from its fundamentals.
Company's own description (FY26 RA, paraphrased)
The company describes itself as a Hong Kong-headquartered contractor engaged mainly in the design, procurement and installation of water circulation systems, including swimming pools, fountains and water curtain walls. It serves developers, main contractors and subcontractors on private residential, hotel, casino, shopping and leisure complex projects in Hong Kong. It says it has extended its scope to design services, building works and renovation projects in Hong Kong. In early 2026 it began trading food, beverage and related products in the PRC.
The FY26 RA Note 1 classifies activities into three streams:
-
Management contracting services: design, procurement, installation and maintenance of water circulation systems.
-
Sales and supply chain of agricultural and health products: a new line launched in March 2026. The MD&A dates the start of food trading to February 2026, a minor internal inconsistency.
-
Consultancy services: consultancy on water circulation systems, plus engineering, procurement and construction management (EPCM) for commercial, residential and infrastructure projects in the PRC. This line was discontinued during FY2026 through the disposal of subsidiaries.
Business model and revenue model
Project-based, tender-driven contracting: Most contracts are won through tender at fixed prices based on estimated scope, duration and cost. Revenue is recognised over time using percentage-of-completion progress billing. All HK$17.64m of FY2026 management contracting revenue was recognised over time (FY26 RA Note 4).
Variation orders: generally carry higher margins than original contract works, which makes profitability lumpy (FY26 RA principal risks (a)).
Subcontracting-heavy cost base: FY2026 contract costs of HK$19.03m included HK$16.56m of subcontractor costs (87%) and HK$2.46m of consumables (FY26 RA Note 7). The group is effectively an asset-light project manager and integrator, not a self-performing installer.
Trading revenue: (sales and supply chain): HK$1.63m in FY2026, recognised at a point in time.
Revenue mix (FY2026, continuing): about 91.6% contracting services and 8.4% product trading. There is no subscription or licensing revenue.
Value-chain position
In Hong Kong's construction value chain, Hao Bai sits as a specialist (nominated or domestic) subcontractor below main contractors, and sometimes contracts directly with developers. It designs systems, procures pumps, filtration and lighting equipment from third-party suppliers, and manages installation subcontractors. It holds no manufacturing assets: PP&E was HK$nil at 31 Mar 2026 (FY26 RA balance sheet).
Customer types and concentration
- Developers, main contractors and subcontractors on private residential, hotel, casino and leisure projects. Since 2026 it also targets public-sector clients (Sha Tin District Office, Architectural Services Department, City University of Hong Kong; announcement 29 May 2026).
Extreme concentration: Customer B contributed HK$12.57m, about 65% of FY2026 continuing revenue. In FY2025, Customers A (HK$10.72m) and B (HK$10.26m) together made up about 88% of continuing revenue (FY26 RA Note 3).
Independent characterisation
On the evidence, Hao Bai has become a sub-scale contractor shell undergoing serial recapitalisation. Its legacy niche in pool and water-feature systems no longer generates profit. The FY2026 gross margin was −5.6%, and cumulative impairments on contract assets and receivables reached about HK$96m over FY2022–FY2026 (S&P/SA cash-flow provisions line). Diversification attempts have been small, short-lived or reversed: PRC consultancy was acquired, then sold; agricultural branding MOUs have not shown up visibly in revenue; a non-binding acquisition MOU lapsed with the deposit refunded. Capital has come mainly from shareholders and creditors converting debt into equity. The public-sector renovation pivot is the most concrete new revenue thread.
Strategy
Stated strategy (FY26 RA, paraphrased themes)
Opportunity seeking in Hong Kong and the PRC: Continue looking for business and investment opportunities in both markets and keep reviewing strategy and potential opportunities internally.
Cost-saving programme: Minimise cash outflow, staff costs and overheads, and control capex.
Government-related tenders: Management contracting is refocusing on government-related tenders and is expected to recover later in FY2027.
Margin recovery: Cost of sales as a share of revenue is expected to fall, and gross margin is expected to turn positive within 12–18 months.
Using its network: to improve the financial position.
Macro framing: Tariffs, high interest rates, cash-flow constraints and unemployment are cited as headwinds. Hong Kong's recovery in exports, finance and tourism is cited as a tailwind, constrained by geopolitics, an ageing population and high operating costs.
Strategic initiatives (last 24 months)
| Date | Initiative | Detail | Status |
|---|---|---|---|
| Late 2024 | Product sales and marketing cooperation with Jiangxi Jingbai Lifei Tech | Expansion into consumer product sales | No separate revenue disclosed |
| Aug 2024–Apr 2025 | Balance-sheet repair via debt capitalisation | Four tranches converting creditor debt to equity | Completed |
| Feb–Jul 2025 | Capital reorganisation | Consolidation, capital reduction, subdivision to enable future fundraising below par | Completed 30 Jul 2025 |
| Jun 2025 | Receivables factoring (up to HK$18m, non-recourse) | To unlock receivables; expected pre-tax loss about HK$3m | Terminated by counterparty 22 May 2026 |
| FY2025–FY2026 | Possible acquisition (non-binding MOU) | HK$14.09m deposit paid to a potential vendor | MOU terminated in FY2026; deposit fully refunded |
| FY2026 | Exit from PRC consultancy/EPCM | Disposal of subsidiaries; gain HK$2.65m | Completed |
| Oct 2025–Feb 2026 | Rights issue (4-for-1 at HK$0.21) | HK$36.94m net | Completed 9 Feb 2026 |
| Feb–Mar 2026 | Launch of PRC food and health product trading | HK$1.63m revenue in FY2026 | Operating |
| Apr 2026 | Placing (HK$3.30m net) | Funds directors' fees, professional and audit fees, working capital | Completed |
| May 2026 | Pivot of rights proceeds to Hong Kong public-sector projects | HK$13m Sha Tin District Office building works; HK$1.5m Architectural Services Department renovation; HK$0.5m City University of Hong Kong renovation | In progress |
Use of rights-issue proceeds
| Use (HKD Mn) | Original allocation | Used by 31 Mar 2026 | Unused 31 Mar 2026 |
|---|---|---|---|
| Trade payables | 13.00 | 11.70 | 1.30 |
| Third-party borrowings | 2.00 | 2.00 | 0 |
| PRC renovation and decoration works | 15.00 | 0 | 15.00 |
| General working capital | 6.94 | 6.94 | 0 |
| Total | 36.94 | 20.64 | 16.30 |
The remaining HK$1.30m for trade payables was used by 30 Jun 2026. The HK$15.0m originally earmarked for a PRC renovation project was re-allocated on 29 May 2026 to the three Hong Kong public-sector projects listed in 10.2.
Medium-term targets and guidance
No quantitative revenue or profit targets have been issued. Qualitative guidance consists of a positive gross margin within 12–18 months, a declining cost-of-sales ratio and a recovery in management contracting revenue later in FY2027. ESG commitments are limited to office-level recycling and energy saving. No emissions targets exist.
Products & Services
Hao Bai does not publish a product catalogue, SKUs, model numbers or pricing. The catalogue below is reconstructed from its filings.
Management Contracting Services
| Offering | Description | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Swimming pool water circulation systems | Design, equipment procurement (pumps, filters, chemical dosing, heating, lighting), installation and commissioning for private residential clubhouses, hotels and resorts | Developers, main contractors | Since 2006 | Fixed-price tender, progress billing (30–60-day credit terms) |
| Water fountains | Design and installation of decorative and choreographed fountain systems for shopping malls, hotels, casinos and public spaces | Developers, casino/hotel operators, main contractors | Since 2006 | Fixed-price tender |
| Water curtains / water walls | Architectural water features for lobbies and façades | Developers, interior fit-out contractors | Since 2006 | Fixed-price tender |
| Maintenance and repair services | Post-handover servicing of installed systems | Property managers, owners | Since 2006 | Service contracts (terms not disclosed) |
| Design services, building works and renovation (Hong Kong) | General building and renovation projects added around 2024 (post-acquisition). Named 2026 projects: Sha Tin District Office building works; Architectural Services Department renovation; City University of Hong Kong renovation | Public-sector bodies, institutions | 2024–2026 | Tendered contracts (values not disclosed) |
Sales and Supply Chain Business (launched Feb/Mar 2026)
| Offering | Description | Target customer | Launch | Pricing |
|---|---|---|---|---|
| Agricultural products trading | Trading and supply-chain services for food products in the PRC | PRC distributors and retailers (not disclosed) | 2,026 | Point-of-sale trading margin (not disclosed) |
| Health products trading | Trading of health and wellness products | — | 2,026 | — |
| Food and beverage trading | Described in the MD&A as food, beverage and related products trading | — | Feb 2026 | — |
Consultancy Services (discontinued FY2026)
| Offering | Description | Status |
|---|---|---|
| Water circulation system consultancy | Advisory services on system design | Discontinued |
| EPCM services (PRC) | Engineering, procurement and construction management for commercial, residential and infrastructure projects in mainland China | Disposed via sale of subsidiaries in FY2026 |
Branding and marketing services (non-revenue-reporting initiatives)
| Initiative | Description | Status |
|---|---|---|
| Agricultural industry branding (Mar 2023) | Hao Bai responsible for branding and marketing of a PRC agricultural partner's products in the PRC and Hong Kong | No separate revenue disclosed |
| Product sales and marketing cooperation with Jiangxi Jingbai Lifei Tech (2024) | Cooperation in product sales and marketing | No separate revenue disclosed |
Financial Narrative
Basis. FY2025–FY2026 figures come from the FY26 RA (audited; FY2025 restated for discontinued operations). FY2022–FY2024 figures come from S&P/SA, which standardises published accounts. EPS is presented on S&P's basis, adjusted for the 2025 share consolidation and the rights-issue bonus element; the company's own FY2026 basic EPS is −39.7 HK cents (FY2025 restated −49.8 cents). All figures are HKD millions unless stated. EBITDA is derived as operating income plus D&A.
Income statement
Revenue CAGR. FY2022–FY2026 (4 years): about 31.4%, flattered by the depressed FY2022 base. FY2023–FY2026 (3 years): about 7.3%. FY2021 revenue was about HK$26.6m (derived from S&P's −75.72% FY2022 decline), so FY2026 revenue remains below the pre-collapse level.
FY2026 P&L bridge (FY26 RA).
Commentary. Three features dominate.
-
Gross margin collapse. Margin fell from 34.3% to −5.6% in FY2026 even though, per management, project volume was broadly unchanged. Cost of sales rose 30% while revenue fell 19%. Subcontractor costs rose from HK$11.92m to HK$16.56m (FY26 RA Note 7), consistent with cost overruns on fixed-price tenders, which is principal risk (d) materialising. Management guides that gross margin will turn positive within 12–18 months.
-
Impairments drive losses. Credit-loss charges totalled HK$32.8m in FY2026 versus HK$17.3m in FY2025. S&P/SA's "provision and write-off of bad debts" line shows HK$21.9m (FY2022), HK$23.4m (FY2023), HK$3.7m (FY2024), HK$17.3m (FY2025) and HK$30.0m (FY2026): about HK$96m cumulatively over five years, roughly 1.2× cumulative revenue (HK$87m). The company is effectively writing off most of the work it bills.
-
Below-the-line items. FY2025 included a HK$5.61m fair-value loss on contingent consideration receivable (likely a profit guarantee linked to the March 2024 acquisition; linkage not confirmed), HK$2.74m of goodwill impairment, and a HK$4.72m gain on waiver of payables. FY2026 included a HK$2.65m gain on disposal of subsidiaries and HK$6.35m of profit from discontinued operations.
Administrative expenses fell 19.3% to HK$4.68m, and staff costs fell from HK$3.05m to HK$2.43m. Cost control is real, but it cannot offset credit losses of this size.
Balance sheet
Note: the company's own FY2026 bank and other borrowings figure is HK$3.337m; S&P's HK$3.47m includes HK$0.13m of lease liabilities. The rise in accumulated losses in FY2026 reflects the capital reduction credit reclassified from share capital (HK$42.19m to HK$2.27m).
FY2026 balance sheet detail (FY26 RA).
Commentary. The balance sheet shrank by 43% in FY2026 because of impairments, collection of the HK$14.1m MOU deposit refund, settlement of payables using rights proceeds (HK$11.7m) and deconsolidation of the PRC consultancy subsidiaries. Equity has been rebuilt from near zero (HK$0.89m at FY2023) to HK$13.9m, but only through external capital: HK$36.94m net from the rights issue offset the HK$30.3m loss. The group moved to net cash of HK$11.9m at 31 Mar 2026 for the first time in five years. Company-defined gearing fell from 94.4% to 24.0% and the current ratio rose from 1.01× to 1.41× (FY26 RA). Contract assets of HK$27.2m (59% of total assets) remain the key valuation risk. Billed-plus-unbilled receivables still represent about 1.5 years of revenue.
Cash flow
Note: S&P records HK$5.40m of FY2023 equity issuance, while the company reports about HK$7.39m net from the January 2023 placing (announcement 3 Nov 2023). The difference likely reflects timing or classification. The four debt capitalisations (Aug 2024 to Apr 2025, about HK$11.9m in aggregate at issue prices) were non-cash and do not appear as equity issuance.
Commentary. Cumulative five-year operating cash flow was about −HK$8.1m. The two positive years (FY2022, FY2025) were driven by stretching payables (+HK$22.0m and +HK$15.1m in AP change) rather than by profitability. FY2026's −HK$11.3m OCF includes a HK$23.5m payables paydown funded by the rights issue. There is effectively no capex. The business has survived on equity raises (about HK$61.9m of cash equity over FY2023–FY2026) plus non-cash debt conversions.
Ratios
ROE and ROA use year-end balances. Ratios are distorted by near-zero equity in FY2023.
Not meaningful or not disclosed.
ROIC: not meaningful. Invested capital (equity + debt − cash) was about HK$2m in FY2026 and NOPAT is deeply negative.
Net debt / EBITDA: not meaningful (EBITDA negative in all five years; net cash in FY2026).
Cash conversion cycle: not disclosed. The company does not report DSO/DPO, and inventory was immaterial until FY2026 (HK$0.08m). The proxy above shows billed-plus-unbilled receivables of 551–881 days of revenue, which indicates a severely extended collection cycle.
Finance costs: used for FY2022–FY2024 coverage are from aggregator data (HK$0.717m, HK$0.409m, HK$0.384m); FY2025–FY2026 are from the FY26 RA (HK$0.534m, HK$0.545m).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Status | What it contains |
|---|---|---|
Management Contracting Services | Continuing (core) | Design, procurement, installation and maintenance of water circulation systems (pools, fountains, water curtains). Since about 2024 it also covers building, design and renovation works in Hong Kong |
Sales and Supply Chain Business | Continuing (new, from Feb/Mar 2026) | Sale and supply chain of agricultural products and health products (food and beverage trading) in the PRC |
Consultancy Services | Discontinued in FY2026 (disposal of subsidiaries) | Water circulation system consultancy; EPCM services for commercial, residential and infrastructure projects in the PRC |
Revenue by Segment
| Segment (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Management Contracting Services revenue | 6.46 | 13.50 | 13.09 | 23.82 | 17.64 |
Sales and Supply Chain revenue | 0 | 0 | 0 | 0 | 1.63 |
Consultancy Services revenue (discontinued from FY2025 restatement) | 0 | 2.10 | 8.79 | 0.68 | 0 |
Total reported revenue (continuing basis) | 6.46 | 15.60 | 21.88 | 23.82 | 19.27 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment result (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Management Contracting Services segment profit | -14.06 | -37.71 |
Sales and Supply Chain segment profit | 0 | 0.24 |
Consultancy Services segment profit (discontinued) | 0.28 | 6.35 |
Segment margin (%)
| Segment margin (%) | FY2025 | FY2026 |
|---|---|---|
Management Contracting Services | -59.0 | -213.8 |
Sales and Supply Chain | 0 | 14.9 |
Consultancy Services | 41.4 | 0 |
Contribution to continuing revenue (%)
| Contribution to continuing revenue (%) | FY2025 | FY2026 |
|---|---|---|
Management Contracting Services | 100.0 | 91.6 |
Sales and Supply Chain | 0 | 8.4 |
YoY growth (%)
| YoY growth (%) | FY2025 | FY2026 |
|---|---|---|
Management Contracting Services | 82.0 | -25.9 |
Segment Assets & Liabilities
| Item (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Management Contracting segment assets | 51.19 | 28.56 |
Sales and Supply Chain segment assets | 0 | 0.29 |
Consultancy segment assets | 9.02 | 0 |
Management Contracting segment liabilities | 41.33 | 13.82 |
Sales and Supply Chain segment liabilities | 0 | 0.76 |
Consultancy segment liabilities | 8.52 | 0 |
Income Statement and Margin Analysis (%)
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue | 6.46 | 15.60 | 21.88 | 23.82 | 19.27 |
Revenue growth (%) | -75.72 | 141.50 | 40.32 | 8.87 | -19.13 |
Gross profit | 1.62 | 3.49 | 5.45 | 8.17 | -1.08 |
Operating income | -29.90 | -9.44 | -10.15 | -14.89 | -35.77 |
Depreciation and amortisation | 0.45 | 0.37 | 1.33 | 0.98 | 0.15 |
EBITDA (derived) | -29.45 | -9.07 | -8.82 | -13.91 | -35.62 |
Pre-tax income (continuing) | -30.44 | -33.17 | -10.02 | -19.21 | -36.43 |
Net income attributable | -30.43 | -33.21 | -10.73 | -19.32 | -30.33 |
EPS basic (HKD, S&P adjusted) | -2.34 | -1.99 | -0.37 | -0.50 | -0.40 |
EPS diluted (HKD, S&P adjusted) | -2.34 | -1.99 | -0.37 | -0.50 | -0.40 |
Dividends per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin (%)
| Margin (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin | 25.01 | 22.36 | 24.89 | 34.29 | -5.60 |
Operating margin | -462.91 | -60.55 | -46.39 | -62.49 | -185.67 |
EBITDA margin (derived) | -455.88 | -58.14 | -40.31 | -58.40 | -184.85 |
Pre-tax margin | -471.20 | -212.64 | -45.81 | -80.63 | -189.10 |
Net margin | -471.20 | -212.92 | -49.01 | -81.09 | -157.42 |
Business Lines
| Line (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Revenue | 23.82 | 19.27 |
Cost of sales | -15.65 | -20.35 |
Gross profit | 8.17 | -1.08 |
Other income and gains (losses) net | -3.79 | 2.65 |
Impairment of intangible assets | 0 | -1.20 |
Impairment of contract assets | -15.60 | -25.04 |
Impairment of trade receivables | -1.66 | -4.98 |
Impairment of deposits and other receivables | 0 | -1.56 |
Administrative expenses | -5.80 | -4.68 |
Finance costs | -0.53 | -0.55 |
Pre-tax loss, continuing | -19.21 | -36.43 |
Income tax | -0.17 | -0.25 |
Profit from discontinued operations | 0.12 | 6.35 |
Loss for the year | -19.26 | -30.33 |
Balance Sheet and Per-Share Data
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets | 73.34 | 84.14 | 107.17 | 81.09 | 46.28 |
Cash and equivalents | 0.11 | 0.25 | 0.17 | 1.82 | 15.41 |
Receivables incl. contract assets (S&P) | 72.38 | 75.40 | 93.37 | 73.78 | 30.17 |
Short-term debt | 6.19 | 22.09 | 0 | 0 | 0 |
Current portion of long-term debt | 9.18 | 6.66 | 6.19 | 5.65 | 3.34 |
Lease liabilities | 0.29 | 0.04 | 2.42 | 0 | 0.13 |
Total debt (S&P) | 15.66 | 28.80 | 8.61 | 5.65 | 3.47 |
Long-term debt | 0 | 0 | 0 | 0 | 0 |
Net debt (negative = net cash) | 15.55 | 28.55 | 8.44 | 3.84 | -11.94 |
Total equity | 17.07 | 0.89 | 11.39 | 5.99 | 13.89 |
Goodwill | 0 | 3.87 | 2.74 | 0 | 0 |
Other intangible assets | 0 | 0 | 0 | 2.70 | 0.17 |
Working capital | 16.60 | -7.21 | 4.25 | 0.66 | 13.26 |
Total current liabilities | 56.27 | 83.25 | 95.07 | 75.10 | 32.40 |
Retained earnings (accumulated losses) | -60.24 | -93.45 | -104.17 | -123.49 | -108.78 |
Book value per share (HKD, S&P) | 1.31 | 0.04 | 0.36 | 0.13 | 0.06 |
Balance Sheet
| Item (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Contract assets | 38.92 | 27.25 |
Trade receivables gross | 31.49 | 3.11 |
Loss allowance on trade receivables | -12.91 | -1.91 |
Other receivables, deposits, prepayments | 16.27 | 1.73 |
Deposit paid to potential vendor (refunded FY2026) | 14.09 | 0 |
Trade and other payables and accruals | 65.62 | 28.07 |
Contract liabilities | 3.18 | 0 |
FVOCI equity investments | 2.63 | 0.30 |
Financial Analysis
| Collection metric (days of revenue) | FY2025 | FY2026 |
|---|---|---|
(Contract assets + net trade receivables) / revenue × 365 | 881 | 551 |
Cash Flow
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow | 17.41 | -18.00 | -6.31 | 10.10 | -11.26 |
Capital expenditure | 0 | 0 | 0 | 0 | 0 |
Free cash flow | 17.41 | -18.00 | -6.31 | 10.10 | -11.26 |
Investing cash flow | 17.45 | 0 | -9.64 | -4.21 | -0.31 |
Net debt issued (repaid) | -27.24 | 13.35 | -1.21 | -3.72 | -11.42 |
Equity issued | 0 | 5.40 | 19.53 | 0 | 36.94 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Financing cash flow | -27.96 | 18.35 | 16.81 | -4.23 | 25.15 |
Net change in cash | 6.90 | 0.36 | 0.85 | 1.65 | 13.59 |
Cash interest paid | 0.72 | 0.40 | 0.32 | 0.52 | 0.38 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | -178.3 | -3,731.5 | -94.2 | -322.5 | -218.4 |
ROA (%) | -41.5 | -39.5 | -10.0 | -23.8 | -65.5 |
Current ratio (x) | 1.30 | 0.91 | 1.04 | 1.01 | 1.41 |
Debt / equity (x) | 0.92 | 32.36 | 0.76 | 0.94 | 0.25 |
Interest coverage, EBIT / finance cost (x) | -41.7 | -23.1 | -26.4 | -27.9 | -65.6 |
Asset turnover, revenue / year-end assets (x) | 0.09 | 0.19 | 0.20 | 0.29 | 0.42 |
Revenue by Region
| Region (HKD Mn, total incl. discontinued) | FY2025 | FY2026 |
|---|---|---|
Hong Kong | 23.82 | 17.64 |
Mainland China | 0.68 | 1.63 |
Total | 24.51 | 19.27 |
Region growth (%) | FY2026 | — |
Hong Kong | -25.9 | — |
Mainland China | 138.6 | — |
Segment (HKD Mn) Overview
| Segment (HKD Mn) | Hong Kong | Mainland China |
|---|---|---|
Management Contracting Services | 17.64 | 0 |
Sales and Supply Chain | 0 | 1.63 |
Consultancy (discontinued) | 0 | 0 |
Locations
| Location (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Hong Kong | 2.63 | 0.45 |
Mainland China | 2.70 | 0.17 |
Share Count (millions) and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Shares outstanding at year end (millions) | 13.00 | 19.53 | 30.95 | 42.19 | 227.47 |
Dividends per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Book value per share (HKD) | 1.31 | 0.04 | 0.36 | 0.13 | 0.06 |
Price-to-sales at fiscal year end (x) | 5.64 | 3.07 | 2.50 | 0.51 | 5.61 |
Valuation Multiples
| Multiple | Hao Bai |
|---|---|
Market cap (HKD Mn) | About 302.8 (236.56m shares) |
Enterprise value (HKD Mn) | About 290.9 (market cap less FY2026 net cash of 11.94; excludes April placing cash) |
P/E | Not meaningful (loss) |
EV/EBITDA | Not meaningful (negative EBITDA) |
EV/Sales | About 15.1× |
P/S | About 15.7× (StockAnalysis) |
P/B | About 21.8× on FY2026 book of HK$13.89m (Lixinger showed 19.4× at HK$1.14) |
Analyst Conclusions
Management guidance (FY26 RA)
-
Management contracting revenue expected to recover later in FY2027 on government-related tenders.
-
Gross margin expected to turn positive within 12–18 months; cost-of-sales ratio expected to decline.
-
Continued cost-saving across staff, overheads and capex.
-
No quantitative revenue or earnings guidance. No consensus exists.
Bull case
-
Clean slate. After the FY2026 write-downs, the PRC exit and the rights issue, the group holds net cash of HK$11.9m, equity of HK$13.9m and no long-term debt. Gearing is 24% versus 94% a year earlier.
-
Visible public-sector pipeline. HK$15m of earmarked funding against three named government and institutional projects, with lower counterparty credit risk than the private-developer contracts that caused the impairments.
-
Operating leverage on recovery. The overhead base is only about HK$4.7m. Returning to FY2025's 34% gross margin on HK$20–25m of revenue would produce a gross profit of HK$7–8.5m, close to administrative break-even before impairments. This is illustrative arithmetic, not guidance.
Bear case
-
The track record is the base case. Losses in every year shown, about HK$96m of credit provisions over five years and five equity or debt-conversion events since 2023 point to a structurally loss-making business. HK$27.2m of remaining contract assets could be impaired further.
-
Dilution is the funding model. The share count rose about 5.6× in FY2026, and the April 2026 placing proceeds went partly to directors' fees and audit costs. Further raises are likely if operating cash flow stays negative (−HK$11.3m in FY2026).
-
Valuation disconnect and governance. At about 15× sales and about 20× book, with no chair or CEO, 65% customer concentration and a thinly traded GEM float, the equity offers asymmetric downside. The stock already fell 13% in one day (18 Aug 2026).
Catalysts and monitorables (next 12 months)
| Item | Expected timing | What to watch |
|---|---|---|
| H1 FY2027 interim results (six months to 30 Sep 2026) | Around Nov 2026 | Gross margin sign; further contract asset impairments; public-project revenue recognition |
| Progress on Sha Tin District Office, Architectural Services Department and City University projects | Ongoing | Revenue contribution; margin; any variation orders |
| Sales and supply chain segment scale-up | Ongoing | Revenue run-rate beyond HK$1.6m; working capital needs |
| Board leadership appointments | Any time | Appointment of a chair or CEO; further director churn |
| New fundraising or M&A | Any time | Placings, rights issues, asset injections; control changes among the about 21%/20%/11% holders |
| FY2027 annual results | Around Jun 2027 | Delivery on positive gross margin guidance |
| GEM compliance | Ongoing | Board composition; sufficiency of operations |
Analyst verdict
Hao Bai International is best understood as a recapitalised GEM micro-cap whose original franchise, specialist pool and fountain contracting in Hong Kong, has failed to earn its cost of capital or even a positive gross margin in the latest year. The five-year record is unambiguous. Revenue has not recovered to its FY2021 level, net losses total HK$124m, and credit-loss provisions exceed cumulative revenue. The business has survived only because shareholders and creditors repeatedly injected or converted capital: a placing, an open offer, a consideration issue, four debt capitalisations, a capital reorganisation, a 4-for-1 rights issue and a further placing, all within about three years.
FY2026 marks a genuine inflection in the balance sheet, though not yet in operations. The group exited PRC consultancy, recovered a HK$14m deposit, moved to net cash and restored GEM board compliance. Management's pivot towards government-related renovation work is the first credible attempt to fix the root problem, counterparty credit risk, and the May 2026 re-allocation of HK$15m to three named public-sector contracts gives it substance. A thin organisation (11 employees), vacant chair and CEO roles, extreme customer concentration and fixed-price tender risk mean execution remains highly uncertain.
The equity valuation is the decisive issue. At about HK$303m, the market prices the company at roughly 15× trailing sales and over 20× book, about six times the price at which shareholders were asked to subscribe in February 2026. Nothing in the disclosed fundamentals supports that multiple. It appears to reflect float dynamics, shell or platform value, or speculation about future corporate actions rather than earnings power.
Verdict: fundamentally high-risk with negative earnings quality. The balance sheet has improved materially, but operating proof is absent. Monitor the November 2026 interim results for evidence of a positive gross margin and stabilised impairments before attributing any value beyond net assets plus listing-platform optionality.
Sources consulted
-
Hao Bai International, Annual Results Announcement for FY ended 31 Mar 2026 (30 Jun 2026), via HKEXnews / pdf.dfcfw.com
-
HKEXnews announcements and circulars: 5 Jan 2023; 12 Jan 2023 placing (per 3 Nov 2023 supplemental); 15 Mar 2023; 24 Apr 2023; 10 Jul 2023; 26 Jan, 29 Jan, 16 Feb, 1 Mar 2024; 26 Aug 2024; 5 Nov and 12 Nov 2024; 24 Feb, 21 Mar, 10 Apr, 16 Apr, 25 Apr, 27 Jun, 29 Jul 2025; 17 Nov 2025; 16 Jun 2026
-
HKSCC Circular CD/DNS/CCASS/020/2023 (Jan 2023 share consolidation)
-
Prospectus (16 May 2017); Annual Reports 2017/18, 2018/19, 2019/20; Quarterly Reports 2017 (irasia.com / HKEXnews)
-
StockAnalysis.com (S&P Global Market Intelligence data): financials overview, balance sheet, cash flow (accessed Oct 2026)
-
ETNet capital-raising register for 8431; Lixinger announcement list and valuation snapshot (Jul 2026)
-
Tiger Brokers news summaries of the Company Information Sheet (9 Feb 2026) and board changes (16 Feb 2026)
-
Moomoo news summaries (2024 board changes, debt capitalisations, Jingbai cooperation); Yahoo Finance and Simply Wall St company profiles
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background / notes | Age |
|---|---|---|---|---|
Ng Wan Lok (吳蘊樂) | Executive Director; signs announcements on behalf of the Board | On board since at least Dec 2022 | Long-serving ED. Historical aggregator pay HK$636k (year not specified) | Born 1968 (Yahoo) |
Wong Wing Hung (王詠紅), Ms | Executive Director | On board since at least Dec 2022; Chairman around Dec 2022 | Former Chairman. Historical aggregator pay HK$589k (year not specified) | Born 1974 (Yahoo) |
Wang Zhixian (王志賢), Ms (pinyin) | Executive Director | 24 Apr 2026 | — | — |
Zhang Jiaqing (張家擎), Mr (pinyin) | Executive Director | 16 Feb 2026 | Diploma in Computer Technology (Jilin University). Senior executive and supply-chain director at a PRC fresh-food chain; 10+ years of liquor-industry sales management. Salary HK$10,000/month plus discretionary bonus | 40 (Feb 2026) |
Cheung Hiu Fung (張曉峯) | INED; Audit Committee member | Dec 2022 | — | — |
Wang Minghui (王明輝), Mr (pinyin) | INED; Audit, Remuneration and Nomination Committees | 16 Feb 2026 | — | 42 (Feb 2026) |
Dong Yicheng (董儀誠), Mr (pinyin) | INED; Chairman of Audit, Remuneration and Nomination Committees | 24 Apr 2026 | Holds appropriate professional accounting qualification (GEM Rule 5.05(2)) | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Source |
|---|---|---|
Dec 2022 | Board: Wong Wing Hung (Chair), Shu Zhongwen, Ng Wan Lok, Wang Xinliang, Wang Lun, Lam Hon Sui; NED Chen Xiaodan; INEDs Ng Kam Chun, Ma Meng, Li Ruyi, Yuen Wai Man; Cheung Hiu Fung appointed INED (late Dec 2022) | Announcements 14 & 28 Dec 2022 |
24 Apr 2023 | Wang Lun Chairman; Shu Zhongwen CEO; INEDs Ma Meng, Li Ruyi, Yuen Wai Man (Audit and Remuneration chair), Cheung Hiu Fung | List of Directors 24 Apr 2023 |
Jan 2024 | EDs Shu Zhongwen (CEO), Wong Wing Hung, Ng Wan Lok, Wang Xinliang; INEDs Ma Meng, Li Ruyi, Yuen Wai Keung (袁偉強), Cheung Hiu Fung | Announcement 29 Jan 2024 |
8 Oct 2024 | Shu Zhongwen resigns as ED, CEO and Nomination Committee chair | Moomoo summary |
Around Oct 2024 | Zhong Yuqing resigns as ED | Moomoo summary |
4 Dec 2024 | Shu Huajuan appointed NED; Li Ruyi resigns as INED; Yiu Chi Wai appointed INED | Moomoo summary |
29 Sep 2025 | NED Shu Huajuan absent from the AGM (Code F.2 deviation) and not re-elected | FY26 RA |
26 Jan 2026 | INED Yuen Wai Keung resigns as Audit, Remuneration and Nomination chair; breach of GEM Rules 5.05, 5.05A, 5.28, 5.34, 5.36A | FY26 RA |
By 9 Feb 2026 | Board per information sheet: Liu Mingqing (Chairman), Ng Wan Lok, Wong Wing Hung, Jiang Bin (EDs); INEDs Cheung Hiu Fung, Yiu Chi Wai | Information sheet summary (Tiger Brokers) |
16 Feb 2026 | Liu Mingqing resigns as ED and Chairman; Mr Zhang appointed ED; Mr Wong appointed INED. Two directors resigned in total; the second is likely Jiang Bin, unconfirmed | Board announcement 16 Feb 2026 |
24 Apr 2026 | New ED appointed (Wang Zhixian); Yiu Chi Wai resigns; Dong Yicheng appointed INED and committee chair; GEM rule re-compliance | FY26 RA; announcement 24 Apr 2026 |
Directors' Remuneration
| Item (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Directors' emoluments (total) | 1.968 | 1.800 |
Other staff salaries and benefits | 1.063 | 0.601 |
Defined contribution | 0.021 | 0.031 |
Major Shareholders
| Holder | Stake (%) | As of | Source / notes |
|---|---|---|---|
Ms Fang Yu Juan | 21.10 | 9 Feb 2026 | Company Information Sheet (secondary summary) |
Ms Leung Yan Fan Youki | 19.75 | 9 Feb 2026 | Same |
Ms Hui Lai Ngar | 10.55 | 9 Feb 2026 | Same. A creditor named 許麗雅 received 13.7m capitalisation shares in Apr 2025; whether this is the same person is unconfirmed |
Harmony Asia International Limited (founding parent) | — | 12 Nov 2024 | Completion announcement |
Public float | At least 25% (company confirmation) | 30 Jun 2026 | FY26 RA |
Competitive Landscape
Key Competitors
| Competitor | Type | Overlap with Hao Bai | Relative positioning (qualitative) |
|---|---|---|---|
Private Hong Kong pool and fountain specialists (numerous; individually unlisted) | Specialist subcontractors | Direct: pool/fountain design and installation | Comparable scale; compete on price in tenders |
E&M divisions of major Hong Kong contractors (for example Gammon, Hip Hing, ATAL; listing status varies) | Main / E&M contractors | Can self-perform or nominate water-feature works | Far larger balance sheets; set subcontract terms |
WAC Holdings (HKEX 8619) | GEM-listed water and drainage engineering contractor | Adjacent: water-related civil works, government tenders | Larger government track record |
Chi Ho Development Holdings (HKEX 8423) | GEM-listed renovation and building works contractor | Direct in Hong Kong renovation pivot | More established in renovation |
Kwong Man Kee Group (HKEX 8023) | GEM-listed flooring and renovation contractor | Adjacent renovation | Niche specialist |
Chi Kan Holdings (HKEX 9913) | HKEX-listed building works contractor | Government building works | Larger public-works experience |
Kingland Group Holdings (HKEX 1751) | HKEX-listed contractor | Building and renovation works | Comparable small-cap |
International fountain specialists (for example OASE Living Water, Crystal Fountains; private) | Equipment makers and design-build specialists | Signature fountain projects (casinos, malls) | Brand and technology leaders |
Fluidra (BME: FDR) | Global pool equipment manufacturer | Supplier rather than competitor; potential vertical integrator | Global scale |
PRC food and health product traders (countless) | Trading companies | New sales and supply chain segment | Hao Bai has no evident advantage |
Competitor Detail
| Metric | Hao Bai (FY2026) |
|---|---|
Revenue (HKD Mn) | 19.3 |
Revenue growth (%) | -19.1 |
Gross margin (%) | -5.6 |
Net margin (%) | -157.4 |
Employees | 11 |
Recent Developments
Headcount rose from 10 to 11.



